Pliva d.o.o. is a Croatian pharmaceutical company, based in Zagreb, Croatia. They are one of the worlds largest producers of generic Adderall, and have seen drastic increases in revenue with an increasing number of patients being diagnosed with Attention Deficit Disorder (ADD). It is the largest pharmaceutical company in Southern Europe, and Croatias third largest exporter. Pliva has recently recast itself as a generic pharmaceutical company leaving its proprietary business behind. Pliva was purchased in December 2008 by the international pharmaceutical company Teva Pharmaceuticals, and operates as part of the Teva Active Pharmaceutical Ingredients (TAPI) division. Pliva operates in over 30 countries worldwide and is the leading pharmaceutical company based in Central and Eastern Europe. It specializes in the development, production and distribution of generic pharmaceutical products, including biologicals, cytostatics, and other generics, as well as active pharmaceutical ingredients.